Views from the Field on Psychedelics in 2026: Excitement, Anxiety, and Open Questions
As we head into what many expect to be a pivotal year, we asked people from across the psychedelics field what they are excited about, concerned by, and hoping to gain clarity on in 2026. What emerges is a picture of tempered anticipation: acceptance of the importance of the year ahead is paired with a sober realism about what pivotal data, regulatory decisions, and access pathways may or may not resolve...
Join Today
Independent data-driven reporting, analysis and commentary on the psychedelics space: from business and drug development through to policy reform and research.
- Regular Bulletins featuring news, analysis, and research
- Articles and deep dives across psychedelic drug development, policy, and research
- Exclusive interviews with researchers, executives, and policymakers
- Bespoke resources and tools including the Psychedelic Bill Tracker
- Quarterly video briefings and slide decks
Already a member?
Sign In